Man Group’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $32.8M | Sell |
68,272
-10,848
| -14% | -$5.55M | 0.06% | 331 |
|
|
2025
Q4 | $44.4M | Sell |
79,120
-9,258
| -10% | -$5.26M | 0.08% | 271 |
|
|
2025
Q3 | $45.4M | Buy |
88,378
+44,394
| +101% | +$19.4M | 0.08% | 281 |
|
|
2025
Q2 | $13.8M | Buy |
43,984
+642
| +1% | +$193K | 0.03% | 649 |
|
|
2025
Q1 | $13.2M | Sell |
43,342
-27,566
| -39% | -$9.27M | 0.03% | 610 |
|
|
2024
Q4 | $23.6M | Sell |
70,908
-52,679
| -43% | -$17.9M | 0.06% | 368 |
|
|
2024
Q3 | $41.3M | Sell |
123,587
-4,167
| -3% | -$1.58M | 0.11% | 245 |
|
|
2024
Q2 | $52.6M | Sell |
127,754
-8,274
| -6% | -$3.28M | 0.13% | 171 |
|
|
2024
Q1 | $55M | Sell |
136,028
-34,917
| -20% | -$12.3M | 0.14% | 160 |
|
|
2023
Q4 | $52.4M | Buy |
+170,945
| New | +$46.1M | 0.15% | 162 |
|
|
2023
Q3 | – | Sell |
-124,866
| Closed | -$31.9M | – | 192 |
|
|
2023
Q2 | $30M | Buy |
+124,866
| New | +$25.9M | 0.09% | 267 |
|
|
2023
Q1 | – | Sell |
-133,751
| Closed | -$27.7M | – | 375 |
|
|
2022
Q4 | $28.4M | Buy |
133,751
+36,856
| +38% | +$7.36M | 0.1% | 249 |
|
|
2022
Q3 | $15.2M | Buy |
+96,895
| New | +$15.5M | 0.07% | 333 |
|
|
2022
Q2 | – | Sell |
-58,577
| Closed | -$8.48M | – | 516 |
|
|
2022
Q1 | $9.58M | Sell |
58,577
-17,348
| -23% | -$2.86M | 0.03% | 624 |
|
|
2021
Q4 | $16.5M | Sell |
75,925
-13,286
| -15% | -$2.78M | 0.05% | 431 |
|
|
2021
Q3 | $16.9M | Buy |
89,211
+10,228
| +13% | +$1.87M | 0.06% | 397 |
|
|
2021
Q2 | $14M | Sell |
78,983
-23,649
| -23% | -$4.08M | 0.05% | 444 |
|
|
2021
Q1 | $16.8M | Sell |
102,632
-98,848
| -49% | -$15.1M | 0.07% | 282 |
|
|
2020
Q4 | $28M | Sell |
201,480
-100,353
| -33% | -$12.6M | 0.12% | 166 |
|
|
2020
Q3 | $33.7M | Buy |
301,833
+83,572
| +38% | +$9.66M | 0.13% | 158 |
|
|
2020
Q2 | $20.3M | Sell |
218,261
-7,755
| -3% | -$660K | 0.1% | 187 |
|
|
2020
Q1 | $16.6M | Sell |
226,016
-141,222
| -38% | -$12.3M | 0.11% | 196 |
|
|
2019
Q4 | $30.9M | Buy |
367,238
+184,221
| +101% | +$14.3M | 0.1% | 234 |
|
|
2019
Q3 | $15.4M | Sell |
183,017
-169,112
| -48% | -$12.8M | 0.06% | 395 |
|
|
2019
Q2 | $23M | Buy |
352,129
+30,862
| +10% | +$1.78M | 0.08% | 304 |
|
|
2019
Q1 | $18.9M | Buy |
321,267
+41,927
| +15% | +$2.5M | 0.07% | 332 |
|
|
2018
Q4 | $14.8M | Sell |
279,340
-217,528
| -44% | -$11.9M | 0.07% | 338 |
|
|
2018
Q3 | $29.8M | Buy |
496,868
+226,300
| +84% | +$12.4M | 0.11% | 200 |
|
|
2018
Q2 | $11.6M | Sell |
270,568
-8,957
| -3% | -$362K | 0.05% | 503 |
|
|
2018
Q1 | $9.76M | Buy |
+279,525
| New | +$10.2M | 0.04% | 506 |
|
Other funds holding MEDP
VPM
VCM
WA
Man Group's MEDP Position: Q1 2026 in Review
Man Group reduced its Medpace (MEDP) stake by 14% in Q1 2026, selling an estimated $5.55M and leaving 68,272 shares worth $32.8M. The position accounts for 0.06% of the portfolio, ranked #331.
Man Group first reported a position in MEDP in Q1 2018 and has held it in 30 quarters since. The position peaked at $55M in Q1 2024. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.
- Man Group held 68,272 shares of Medpace worth $32.8M as of Q1 2026.
- Man Group sold 10,848 Medpace shares in Q1 2026, an estimated $5.55M.
- Medpace made up 0.06% of Man Group's portfolio in Q1 2026, its #331 holding.
- Man Group first reported a position in Medpace in Q1 2018 and has held it in 30 quarters since.
- Man Group's Medpace position peaked at $55M in Q1 2024.
- 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.
Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.